Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.

Slides:



Advertisements
Similar presentations
V Glaucoma Implementing NICE guidance 2009 NICE clinical guideline 85.
Advertisements

Implementing NICE guidance
Paras Guide to Glaucoma
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Quality Improvement/ Quality Assurance Amelia Broussard, PhD, RN, MPH Christopher Gibbs, JD, MPH.
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Providing the full range of Local Enhanced Services: The case of Manchester Karen O’Brien Associate Director Primary Care Commissioning.
ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.
Physician Compliance With the HEDS Recommendation of Antiviral Prophylaxis in Patients Diagnosed With Herpetic Stromal Keratitis at KEI Sameen Zaidi M.D.
Area 4 SHARP Face-to-Face Conference Phenotyping Team – Centerphase Project Assessing the Value of Phenotyping Algorithms June 30, 2011.
By Dr Obinna Awiaka O.D,MNOA President & CEO Eyemasters Ltd Occupational Vision Specialists.
0 Glaucoma can take your sight away. Keep Vision in Your Future.
The findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the CDC. CDC ‘s Role in Vision.
Community Ophthalmology Lecture Series Lecture Ⅲ.
Assessment and Management of Patients With Eye and Vision Disorders
Haley Hyde Jessica Fordham Jena Hamm  Colorectal cancer is a leading cause of cancer related deaths every year.  150,000 Americans will be diagnosed.
Quality Improvement Prepeared By Dr: Manal Moussa.
DOCUMENTATION GUIDELINES FOR E/M SERVICES
The Effect of the Restor Multifocal IOL on Frequency Doubling Perimetry Elizabeth Yeu, MD1, Elizabeth Woznak, BS2, Nicole Kesten, BS2, Steven VL Brown,
Chapter 17 Nursing Diagnosis
The Canadian Association of Optometrists
Better Health. No Hassles. A Healthy Eyes Healthy People Presentation Glaucoma… Knowing the Facts Can Save Your Sight.
Dr G. Chandrasekhar LVP Eye Health Pyramid Glaucoma Care.
OPEN ANGLE GLAUCOMA Frank J. Weinstock, MD, FACS Professor of Ophthalmology- NEOUCOM Canton, Ohio USA.
The Diabetic Retinopathy Clinical Research Network
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
 GLAUCOMA.  BY GROUPS 3 1. Siti Hadijah ( ) 2. I Putu Adi Styawan ( ) 3. Jaka Primadhana. R ( ) 4. Komang Ayu Pradnya Antari ( )
Will my Glaucoma patient lose vision ?
Wound Treatment in Long Term Care
1 Confidential MRA Overview Yasmin McLaughlin,CPC SER Manager For internal use only.
Slide 1 Long-Term Care (LTC) Collaborative PIP: Medication Review Tuesday, October 29, 2013 Presenter: Christi Melendez, RN, CPHQ Associate Director, PIP.
The Value of Medication Therapy Management Services.
June 11, IOM, Reducing Suicide, 2002 Statement of Task w Assess the science base w Evaluate the status of prevention w Consider strategies for studying.
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
Diabetes Mellitus Primary Care QI Project – Year III Mary Altier, RN, Bonnie Fiala-Bayser, Ph.D., William Cannon, MD, David Goldberg, MD, Jan Jandrisits,
Purpose: Introduction:  At initial evaluation: For post-op day # 0 patients: Pre-op VA was 20/50.6 (0.395 ± 0.198); Post-op VA was 20/102.0 (0.196 ± 0.162);
January is Glaucoma Awareness Month The information and recommendations appearing on these pages are informational only and is not intended to be a basis.
Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
BlueCross BlueShield of Tennessee, Inc., an Independent Licensee of the BlueCross BlueShield Association. This document has been classified as public Information.
Clinical Assessment Program for Residencies Jim Czarnecki, D.O.
Glaucoma… Knowing the Facts Can Save Your Sight A Healthy Eyes Healthy People Presentation.
Basic Nursing: Foundations of Skills & Concepts Chapter 9
CLINICAL AUDIT A quick guide. Why Audit? ‘Clinical audit is about improvement. If you are not changing or improving things as a result of audit then ask.
Fundamental Nursing Skills and Concepts Chapter 2.
RETINOPATHY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Blindness or low vision effects more than 3 million Americans 40 years and older, and this number is projected to reach 5.5 million by In addition.
Beyond the First Year of MU in 2014 Clinical Quality Measures and the Physician Quality Reporting System Presenters: Randy Marsden – Chief Client Officer.
Reducing Surveillance Bias in Adverse Events Reporting in an Unmasked Treatment Trial Mae Gordon, Julia Beiser, Patricia Morris, J. Philip Miller, Michael.
Glaucoma Madhav Vempali Vempali Medical Ltd. Glaucoma The healthy eye Light rays enter the eye through the cornea, pupil and lens. These light rays are.
Overcoming the Risk Adjustment Payment Challenge John G. Lovelace, President July 2010.
Glaucoma Lily T. Im, MD. What is glaucoma?   Glaucoma is a group of diseases that damage the eye’s optic nerve and can result in vision loss and blindness.
A Deeper Look at Sight Threatening Conditions: Glaucoma, Macular Degeneration, and Diabetic Retinopathy Ashley S. Reddell, OD, FCOVD HOACLS 2015.
(Relates to Chapter 22, “Nursing Management: Visual and Auditory Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier.
Understanding Glauco ma. Femi Babalola Rachel eye center Garki, Abuja.
Glaucoma “ The Sneak Thief of Sight." Julie DeMore Professor Don Williams NS215G.
Ocular Manifestations of Diabetes
Ophthalmology – Raised IOP Referrals (Adults only)
Safety of medication reduction for Primary Angle Closure (PAC) –
Spartanburg Family Medicine Residency
VISUAL ALTERATION GLAUCOMA.
At the end of this talk, the resident will be able to:
Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Year 1 Results Lisa A. Hark, PhD, RD; Michael Waisbourd, MD; Kamran Rahmatnejad, MD;
Understanding Risk Scoring
Glaucoma.
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Clinical Cases in Glaucoma Treatment
Concepts of Nursing NUR 212
Chapter 2 Nursing Process
I-Chan Lin MD, Paul P. Lee MD, JD
Presentation transcript:

Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity or Problem Statement: To standardize the initial treatment of chronic open angle glaucoma and ocular hypertension.

Goals Attempt to maintain IOP at or below this target level by initiating appropriate therapeutic intervention(s). Monitor the status of the optic nerve for further damage. Minimize the side effects of management and their impact on the patient’s vision, general health, and quality of life. Minimize the financial impact of treatment on the patient.

Goals Document the status of optic nerve structure (disc photos and drawings) and function (visual fields) on presentation. Estimate a pressure below which further optic nerve damage is unlikely to occur (target pressure).

Background Primary open-angle glaucoma (POAG) is a major health problem. Glaucoma is the second most common cause of blindness in the US and the leading cause of blindness among African Americans. 2.5 million Americans have POAG; half of them may be unaware that they have the disease. About 130,000 Americans are blind from glaucoma and any others are visually handicapped.

Background In the US, more than 7 million office visits occur per year for the primary purpose of monitoring patients with glaucoma and patients at risk for developing glaucoma. The magnitude of the problem will increase as the American population ages.

Most Likely Causes Identified Through Data Individual physicians use differing, nonstandardized management strategies. Critical elements of the clinical history, physical examination, and ancillary studies may not be completed. A target pressure may not be identified, and subsequent care not focused on achieving this target pressure, as well as detecting clinical progression.

Solutions Implemented A Glaucoma Care Flowsheet was implemented on 4/22/02. A flowsheet is initiated for all patients with newly diagnosed glaucoma or ocular hypertension and their clinical course monitored. In addition, we have undertaken a retrospective review of patients diagnosed before the care management guidelines were initiated to measure the effect of implementation.

Measured elements- History Review of family, ocular, and systemic history Review of pertinent records, esp. status of optic nerve, visual field, and IOP Use of ocular and systemic medications Ocular surgery Known local or systemic intolerance to the use of glaucoma medications Time of last use of glaucoma medications Severity and outcome of glaucoma in family members Assessment of the impact of visual function on daily activities.

Measured Elements- Physical Examination Pupils Slit-lamp examination Intraocular pressure with time of day recorded Corneal pachymetry Gonioscopy Examination of optic nerve head and retinal nerve fiber layer (magnified stereoscopic visualization through a dilated pupil Color stereo photographs of the optic nerve Detailed drawing of the optic nerve Examination of the fundus through a dilated pupil Visual field evaluation (via automated static threshold perimetry)

Measured Elements- Treatment Establishment of a target pressure (i.e. upper limit of a range of intraocular pressures deemed likely to slow or stop further optic nerve damage) Initial target pressure should be at least 20-30% lower than the pretreatment range. Topical ocular hypotensive treatment should be performed by monocular trial. Effectiveness of treatment in reaching and maintaining target pressure over a 1 year period.

Methods 100 charts of patients carrying the diagnosis of primary open-angle glaucoma or POAG (ICD-9 code ) seen in the ophthalmology clinic in the years 2000 and 2001 were reviewed. 12 met the criteria of newly diagnosed POAG. Since implementation of the care management protocol, 35 patients newly diagnosed with POAG have been identified. 5 patients with ocular hypertension or glaucoma suspects are not included in the analysis.

Data chosen for initial analysis Documentation of family history of glaucoma Gonioscopy Examination of the fundus through a dilated pupil Color stereo photographs of the optic nerve. Other data will continue to be collected and will be analyzed once data collection is complete.

Results

Recommendations for Further Study and Action A high rate of compliance with assessment of family history and performance of dilated fundus examination is seen in the current group of patients and in historical controls. Compliance with gonioscopy and stereo fundus photos has been low, but has improved in the past three months.

Recommendations for Further Study and Action Results have been shared with faculty, residents, and clinical staff in a Grand Rounds format to enhance understanding of and compliance with the management protocol. Compliance with the protocol will be followed in monthly meetings and in quarterly reports. We will examine compliance with other elements of the care standards as well.